Advanced

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

Bengtsson, D.; Schrøder, H. D.; Berinder, K.; Maiter, D.; Hoybye, C.; Ragnarsson, O.; Feldt-Rasmussen, U.; Krogh Rasmussen, Å.; van der Lely, A. and Petersson, M., et al. (2018) In Endocrine 62(3). p.737-739
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Endocrine
volume
62
issue
3
pages
737 - 739
publisher
Humana Press
external identifiers
  • scopus:85053657322
ISSN
1355-008X
DOI
10.1007/s12020-018-1751-9
language
English
LU publication?
yes
id
1d38974c-c835-45ee-8c25-56635ade072f
date added to LUP
2018-10-24 16:16:35
date last changed
2019-03-12 04:17:05
@article{1d38974c-c835-45ee-8c25-56635ade072f,
  author       = {Bengtsson, D. and Schrøder, H. D. and Berinder, K. and Maiter, D. and Hoybye, C. and Ragnarsson, O. and Feldt-Rasmussen, U. and Krogh Rasmussen, Å. and van der Lely, A. and Petersson, M. and Johannsson, G. and Andersen, M. and Burman, P.},
  issn         = {1355-008X},
  language     = {eng},
  month        = {09},
  number       = {3},
  pages        = {737--739},
  publisher    = {Humana Press},
  series       = {Endocrine},
  title        = {Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide},
  url          = {http://dx.doi.org/10.1007/s12020-018-1751-9},
  volume       = {62},
  year         = {2018},
}